Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice
PLoS ONE - United States
doi 10.1371/journal.pone.0210225
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 9, 2019
Authors
Publisher
Public Library of Science (PLoS)